Ethos Financial Group, LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1954242
KING OF PRUSSIA, PA
Position in VKTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$786,324
+$330,374 QoQ
Shares Held
20,157
+43.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#184
of 434 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ethos Financial Group, LLC holds $1,531,772 across 7 Biotechnology names. VKTX ranks #1 (51.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
This page
|
20,157 | $786,324 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
464 | $230,482 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
731 | $220,052 | |
| 4 | SLS |
SELLAS Life Sciences Group, Inc.
|
10,000 | $147,600 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
20,398 | $74,860 | |
| 6 | NRXP |
NRX Pharmaceuticals, Inc.
|
15,900 | $65,031 | |
| 7 | 39,070 | $7,423 |
All Filings in VKTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $786,324 | 20,157 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $455,950 | 14,012 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $492,942 | 14,012 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $288,265 | 10,969 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $279,522 | 10,548 | Shares | Sole | 2025-08-06 | |
| No filing history on record for this holder in this stock. | ||||||